| scholarly article | Q13442814 |
| P50 | author | Mary E Ballestas | Q37381877 |
| P2093 | author name string | Kenneth M Kaye | |
| P2860 | cites work | DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 |
| Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres | Q24292850 | ||
| Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA | Q24299259 | ||
| Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4 | Q24305951 | ||
| Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase | Q24309461 | ||
| Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA | Q24310313 | ||
| Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket | Q24321867 | ||
| Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 | ||
| Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 | ||
| Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes | Q24538878 | ||
| A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase | Q24540065 | ||
| Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
| Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q24646461 | ||
| MeCP2, a key contributor to neurological disease, activates and represses transcription | Q24647533 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus | Q24670086 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes | Q24673761 | ||
| BRD4 Bromodomain Gene Rearrangement in Aggressive Carcinoma with Translocation t(15;19) | Q24685696 | ||
| Plasticity of DNA replication initiation in Epstein-Barr virus episomes | Q24793031 | ||
| Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers | Q27486093 | ||
| Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association | Q27643414 | ||
| Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism | Q27766428 | ||
| BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma | Q28204751 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes | Q28258520 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta | Q35104781 | ||
| Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen | Q35123088 | ||
| Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation | Q35137826 | ||
| Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest | Q35139294 | ||
| Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy | Q35233148 | ||
| Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. | Q35635426 | ||
| Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. | Q35664106 | ||
| Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers | Q35678361 | ||
| Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding | Q35785433 | ||
| Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. | Q35884473 | ||
| Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein | Q36019173 | ||
| Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance | Q36098894 | ||
| The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc | Q36099076 | ||
| HHV-8 infection in African children | Q36162572 | ||
| A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells | Q36263086 | ||
| The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency | Q36524534 | ||
| KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 | ||
| A charged and contoured surface on the nucleosome regulates chromatin compaction | Q36631074 | ||
| The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase | Q36727254 | ||
| A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus | Q36885800 | ||
| The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4 | Q36994613 | ||
| Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program | Q37060535 | ||
| Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin | Q37110728 | ||
| The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters | Q37157234 | ||
| Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence | Q37157253 | ||
| Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta | Q37204595 | ||
| Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma | Q37284423 | ||
| HIV-associated lymphomas and gamma-herpesviruses. | Q37310043 | ||
| Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus | Q37410861 | ||
| ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. | Q37511491 | ||
| Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA. | Q37682920 | ||
| Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. | Q38360539 | ||
| Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa | Q39122647 | ||
| Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines | Q39612332 | ||
| Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores | Q39675686 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. | Q39700420 | ||
| Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription | Q39711148 | ||
| Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas | Q39744147 | ||
| Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex | Q39749787 | ||
| KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming | Q39751014 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation | Q39852047 | ||
| Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. | Q39960021 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 | ||
| An autonomous replicating element within the KSHV genome | Q40051226 | ||
| ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication | Q40094006 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids | Q40150286 | ||
| Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen | Q40169138 | ||
| Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. | Q40176573 | ||
| The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner | Q40199723 | ||
| Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes | Q40231171 | ||
| Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx | Q40252446 | ||
| ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin | Q40276488 | ||
| KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity | Q40286016 | ||
| KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo | Q40303480 | ||
| Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats | Q40317413 | ||
| The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. | Q40318272 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function | Q40335991 | ||
| Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 | ||
| Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus | Q40574604 | ||
| Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection | Q40598301 | ||
| Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. | Q40635358 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. | Q40682995 | ||
| Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts | Q40697742 | ||
| Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma | Q40865709 | ||
| Interaction of the papillomavirus E2 protein with mitotic chromosomes | Q40885434 | ||
| Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies | Q40914940 | ||
| Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. | Q40923894 | ||
| The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells | Q41112391 | ||
| Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen | Q41849965 | ||
| The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains | Q41860564 | ||
| Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus | Q41891421 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus | Q42425041 | ||
| Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies | Q42665921 | ||
| RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells | Q42693319 | ||
| Histone modification pattern of the T-cellular Herpesvirus saimiri genome in latency | Q42798061 | ||
| Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia | Q43467153 | ||
| Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. | Q43932714 | ||
| DNMT1 is a component of a multiprotein DNA replication complex | Q44291313 | ||
| Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. | Q45596372 | ||
| ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. | Q47360085 | ||
| Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus | Q56794246 | ||
| The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus | Q57662902 | ||
| KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence | Q60178445 | ||
| Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution | Q70582465 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
| KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA | Q28474913 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus | Q30479353 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation | Q30482603 | ||
| A green fluorescent protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a prey expression plasmid: application to interaction screening | Q30869796 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences | Q33265370 | ||
| Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency | Q33545232 | ||
| Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency | Q33648926 | ||
| Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 | ||
| Epigenetics: regulation through repression | Q33751823 | ||
| Relationships between chromatin organization and DNA methylation in determining gene expression | Q33765668 | ||
| Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin | Q33781363 | ||
| Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus | Q33805275 | ||
| Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. | Q33817882 | ||
| The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation | Q33834414 | ||
| Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33835021 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. | Q33838228 | ||
| Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes | Q33851443 | ||
| DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33853499 | ||
| Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells | Q33854704 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
| Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin | Q33884073 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells | Q33934809 | ||
| Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome | Q33966678 | ||
| Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection | Q33967384 | ||
| Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway | Q34092628 | ||
| Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. | Q34092739 | ||
| Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. | Q34107917 | ||
| Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication | Q34128791 | ||
| Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma | Q34168712 | ||
| The Viral Latency-Associated Nuclear Antigen Augments the B-Cell Response to AntigenIn Vivo | Q34178308 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 | ||
| Variations in the association of papillomavirus E2 proteins with mitotic chromosomes | Q34250737 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha. | Q34276926 | ||
| Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q34292265 | ||
| Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus | Q34333300 | ||
| The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites | Q34344734 | ||
| Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. | Q34348453 | ||
| Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice | Q34349469 | ||
| Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1 | Q34350776 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells | Q34355092 | ||
| Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
| The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma | Q34391203 | ||
| Epigenetics: interaction of DNA methylation and chromatin | Q34438141 | ||
| Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection | Q34462040 | ||
| The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen | Q34494872 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. | Q34531461 | ||
| Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | Q34548882 | ||
| The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence | Q34553975 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma | Q34579974 | ||
| The molecular pathology of Kaposi's sarcoma-associated herpesvirus | Q34605505 | ||
| The Histone Chaperone FACT: Structural Insights and Mechanisms for Nucleosome Reorganization | Q34628070 | ||
| Cloning and molecular characterization of the murine herpesvirus 68 genome | Q34631413 | ||
| Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen | Q34735858 | ||
| HHV8 and Kaposi's sarcoma: a time cohort study | Q34741956 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells | Q34976840 | ||
| The Latency-Associated Nuclear Antigen Homolog of Herpesvirus Saimiri Inhibits Lytic Virus Replication | Q34977304 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells | Q34997083 | ||
| Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription | Q35007045 | ||
| Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 | ||
| P433 | issue | 12 | |
| P1104 | number of pages | 15 | |
| P304 | page(s) | 1399-1413 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Future Microbiology | Q15759961 |
| P1476 | title | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency | |
| P478 | volume | 6 |
| Q35973676 | A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. |
| Q40458274 | A chimeric protein composed of NuMA fused to the DNA binding domain of LANA is sufficient for the ori-P-dependent DNA replication. |
| Q36255788 | BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency |
| Q35075128 | Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. |
| Q36086302 | Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q41947834 | Cohesins Repress Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Gene Transcription during Latency |
| Q47549299 | Conditional mutagenesis in vivo reveals cell type- and infection stage-specific requirements for LANA in chronic MHV68 infection |
| Q36646579 | Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS |
| Q47550300 | Detecting TF-miRNA-gene network based modules for 5hmC and 5mC brain samples: a intra- and inter-species case-study between human and rhesus |
| Q40490396 | Detection of ORF6 protein associated with latent KHV infection |
| Q39091793 | Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes |
| Q38100381 | Epigenetic regulation of EBV and KSHV latency |
| Q38833222 | Epigenetics and Genetics of Viral Latency |
| Q91591725 | Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC |
| Q35720026 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses |
| Q35758587 | Inefficient Codon Usage Impairs mRNA Accumulation: the Case of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q39046910 | KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation |
| Q37237030 | KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription |
| Q38692823 | KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
| Q33632932 | Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency |
| Q40417350 | Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients |
| Q39320195 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Recruits Topoisomerase IIβ for Latent DNA Replication of the Terminal Repeats |
| Q26865827 | Keeping it quiet: chromatin control of gammaherpesvirus latency |
| Q28540872 | LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex |
| Q64232572 | LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency |
| Q36126100 | LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection |
| Q36038346 | Localization of latency-associated nuclear antigen (LANA) on mitotic chromosomes |
| Q27680411 | Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA |
| Q35014918 | Molecular biology of KSHV lytic reactivation |
| Q38659314 | Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs |
| Q38535445 | New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA. |
| Q26752599 | Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology |
| Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
| Q28540651 | Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesis |
| Q41306617 | Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA. |
| Q47551073 | RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism |
| Q26751238 | Recent advances in understanding Kaposi's sarcoma-associated herpesvirus |
| Q64375144 | Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene |
| Q37064368 | Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection |
| Q132042932 | Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? |
| Q36497017 | Telomeres and viruses: common themes of genome maintenance. |
| Q35669267 | The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA |
| Q38725485 | The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency |
| Q37252776 | The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
| Q38318452 | Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability |
| Q38494694 | Touch, act and go: landing and operating on nucleosomes |
| Q60909604 | Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies |
| Q36761560 | Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. |
Search more.